The Value of Palliative Primary Tumor Resection in Metastatic Colon Cancer
Status:
Recruiting
Trial end date:
2025-12-31
Target enrollment:
Participant gender:
Summary
The aim of this trial is to evaluate the value of palliative primary tumor resection in colon
cancer patients with initially unresectable metastases and a positive response to induction
chemotherapy which depends on gene testing. The primary endpoint is to evaluate overall
survival.